These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 834521)

  • 1. Safety and effectiveness of over-the-counter drugs: the FDA's OTC drug review.
    Pediatrics; 1977 Feb; 59(2):309-11. PubMed ID: 834521
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(33):7919-21. PubMed ID: 12593411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Oct; 70(195):58974-7. PubMed ID: 16217879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiperspirant drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(110):34273-93. PubMed ID: 12795305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(15):3060-76. PubMed ID: 11820251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 May; 69(92):26301-2. PubMed ID: 15141675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; final rule for over-the-counter antitussive drug products; technical amendment. Final rule, technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Nov; 72(230):67639-40. PubMed ID: 18064767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiarrheal drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Apr; 68(74):18869-82. PubMed ID: 12701600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(228):69278-80. PubMed ID: 15570675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(236):68509-11. PubMed ID: 14664244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(27):5942-3. PubMed ID: 11837282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeling for bronchodilators to treat asthma; cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jul; 76(143):44475-89. PubMed ID: 21796845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
    Moxley JH; Yingling GL; Edwards CC
    Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
    [No Abstract]   [Full Text] [Related]  

  • 16. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(90):31125-7. PubMed ID: 12001972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ-specific warnings; internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Apr; 74(81):19385-409. PubMed ID: 19507324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
    Fed Regist; 2006 Aug; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorectal drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Aug; 68(165):51167-70. PubMed ID: 12952012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.